http://orcid.org/0000-0002-3707-1166
Figures
Abstract
Dietary energy intake strongly linked to dialysis outcomes. We aimed to explore the optimal cut-off point of energy intake (EI) for identification of metabolic syndrome (MetS) in hemodialysis patients. The cross-sectional data of 243 hemodialysis patients from multi-dialysis centers in Taiwan was used. The dietary intake was assessed by using the three-day dietary questionnaire, and a 24-hour dietary recall, clinical and biochemical data were also evaluated. The MetS was diagnosed by the Harmonized Metabolic Syndrome criteria. The receiver operating characteristic (ROC) curve was to depict the optimal cut-off value of EI for the diagnosis of MetS. The logistic regression was also used to explore the association between inadequate EI and MetS. The optimal cut-off points of EI for identifying the MetS were 26.7 kcal/kg/day for patients aged less than 60 years, or with non-diabetes, and 26.2 kcal/kg/day for patients aged 60 years and above, or with diabetes, respectively. The likelihood of the MetS increased with lower percentiles of energy intake in hemodialysis patients. In the multivariate analysis, the inadequate dietary energy intake strongly determined 3.24 folds of the MetS. The assessment of dietary EI can help healthcare providers detecting patients who are at risk of metabolic syndrome.
Citation: Duong TV, Wong T-C, Chen H-H, Chen T-W, Chen T-H, Hsu Y-H, et al. (2018) The cut-off values of dietary energy intake for determining metabolic syndrome in hemodialysis patients: A clinical cross-sectional study. PLoS ONE 13(3): e0193742. https://doi.org/10.1371/journal.pone.0193742
Editor: Yu Ru Kou, National Yang-Ming University, TAIWAN
Received: November 26, 2017; Accepted: February 16, 2018; Published: March 14, 2018
Copyright: © 2018 Duong et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Taipei Medical University Joint Institutional Review Board, and the Institutional Review Boards in Cathay General Hospital, and Taipei Tzu-Chi Hospital have placed restrictions on public data sharing because the dataset contains sensitive and identifying information. Any modification or de-identification on the dataset is restricted. The authors confirm that the data is available upon request. Requests may be sent directly to the corresponding author, SHY (sherry@tmu.edu.tw), or TVD (duongtuyenvna@gmail.com), or TCW (wdz5@ulive.pccu.edu.tw). Data queries may also be sent to Institutional Review Boards in Taipei Medical University via email: ohr@tmu.edu.tw and tmujirb@gmail.com; in Cathay General Hospital via email: irb@cgh.org.tw; and Taipei Tzu-Chi Hospital via email: xdirb@tzuchi.com.tw.
Funding: The research was supported by Ministry of Science and Technology in Taiwan (NSC 102-2320-B-038-026, MOST 105-2320-B-038-033-MY3).
Competing interests: The authors have declared that no competing interests exist.
Introduction
The end-stage renal disease (ESRD) has been steadily increased over the past decades and well-recognized as a heavy burden for every healthcare system in the world [1]. Taiwan experienced the highest number of hemodialysis patients in the world with 3093 dialysis per million population, 90% of patients receiving in-center hemodialysis [1]. However, the number of healthcare providers such as nephrologists, dietitians, or nutritionists has not increased to meet the greater demand of this group of patients in renal care [2].
Metabolic syndrome (MetS) showed the causal association with progressive decline in renal function [3]. MetS was reported with high prevalence in the end-stage renal disease (ESRD) patients undergoing hemodialysis, ranged from 61.0% diagnosed in Taiwan using criteria set by the adult treatment panel III (ATP-III) [4], to 75.3% diagnosed in Brazil according to the Harmonizing the Metabolic Syndrome (HMetS) criteria [5]. MetS has been practically established as the risk factor for cardiovascular disease, type 2 diabetes, and increase in all-cause [5–10], and predicted the risk of hospitalization [11]. On the other hand, the progression of renal disease may lead to elevated blood pressure, hypertriglyceridemia, and other metabolic alterations which may further add to the incidence and prevalence of metabolic syndrome [12]. The progressive decline of renal function even induce the onset of insulin resistance and diabetes independent of previous diabetic and nutritional status [10]. In addition, specific treatment modalities may have a negative metabolic effect favoring the onset of metabolic abnormalities [12].
The detection of MetS and nutritional interventions were the most critical recommendations, in order to have adequate interventions to reduce the unfavorable consequences [13,14]. Dietary approaches have been recognized as the effective therapy to prevent several risk factors and its unfavorable consequences in patients with chronic diseases, especially to prevent metabolic complications, and reduce the metabolic syndrome alteration [15–18]. A potential justification for the increased energy dietary intake was recommended in the National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines [19,20].
The inadequate energy intake (IEI) was high prevalence, accounted for about two third of hemodialysis patients [21,22]. The randomized controlled trial on patients with metabolic syndrome concluded that dietary approaches reduced most of the metabolic risk factors [14]. Dietary energy intake has been well recognized as a determinant of metabolic syndrome. However, there has been none of the studies estimate the cut-off value of energy intake, which can detect the MetS.
In order to face and overcome these critical problems of limited human resource and to lower the cost of diagnostic tests and treatment, dietary intake assessment has become vitally important to identify metabolic syndrome in hemodialysis patients. The current study used the data from multi-dialysis centers in Taiwan to explore the optimal cut-off point of energy intake for identification of MetS in hemodialysis patients.
Methods
Study design and patient population
The hemodialysis (HD) patients were recruited from a clinical cross-sectional study, which was conducted between September 2013 and November 2016. The data of 243 HD patients in hemodialysis centers from five hospitals in Taiwan including 58 from Taipei Medical University Hospital, 55 from Taipei Tzu-Chi Hospital, 52 from Taipei Medical University–Wan Fang Hospital, 42 from Cathay General Hospital, 36 from Taipei Medical University–Shuang Ho Hospital. The sample size was adequate for a clinical observational design.
Patients who aged above 20 years, received thrice-weekly hemodialysis treatment for at least 3 months, adequate dialysis quality (equilibrated Kt/V ≥ 1.2 g/kg/day) were recruited. Patients who had one of the following criteria were excluded: who diagnosed with edema, pregnancy, amputation, hyperthyroidism, hypothyroidism, malignancy, received tube feeding, exhibited hepatic failure or cancer, hospitalized within one month prior to the recruitment, or were scheduled for surgery. In the current study, patients have not been in diet control for overweight or obesity. They have been advised to follow the K/DOQI guidelines [23], and healthy eating guidelines in Taiwan [24,25].
Dietary energy intake
The dietary intake was evaluated via the three-day dietary record (one day of hemodialysis, one day of non-hemodialysis, and one day in the weekend), and a 24-hour dietary recall with common household measuring utensils was also administered as the means to confirm the data, which described in details elsewhere [26,27]. In brief, patients were asked about meal time, meal location, food names, brand names, ingredients, portion or weight of foods, and the different cooking methods and oils used. The nutrients were then analyzed e-Kitchen software (Nutritionist Edition, Enhancement plus 3, version 2009, Taichung, Taiwan).
The guidelines of National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI) recommended that the optimal targets for dietary energy intake in hemodialysis patient were ≥ 35 kcal/kg/day if age < 60, and ≥ 30 kcal/kg/day if age ≥ 60, respectively [19,20]. Patients consumed less than those cut-off points were classified as inadequate dietary energy intake.
Clinical and laboratory data
The body compositions including height (cm), weight (kg), body mass index, BMI (kg/m2), and waist circumference, WC (cm) were measured by bioelectrical impedance analysis (BIA) (InBody S10, Biospace, Seoul, Korea), the measurement procedures was performed according to manufacturer guidelines as described details elsewhere [28]. The hemodialysis vintage, comorbidities (diabetes mellitus, hypertension, cardiovascular diseases, and others), systolic blood pressure, diastolic blood pressure before each hemodialysis session were also assessed by reviewing patients’ medical records. The comorbidity index was calculated by adapted the Charlson comorbidity index for end-stage renal disease patients [29].
Physical activity was assessed by the short version of the International Physical Activity Questionnaire (IPAQ-SF) with 7 items was used in this study. The total time spent on physical activity was the sum of total minutes over last seven days spent on the vigorous activity, moderate activity, walking, and sitting multiplied by 8.0, 4.0, and 3.3, 1.0, respectively [30]. The time spent on physical activity was then transformed into the metabolic equivalent task minute per week (MET- min/wk), to create MET scores, this scoring method was used in several studies [31].
The serum level of high-sensitive C-reactive protein (hs-CRP), fasting plasma glucose (FPG), triglyceride (TG), and high-density lipid cholesterol (HDL-C) were archived from laboratory tests. The elevated level of high-sensitive C-reactive protein (hs-CRP) was classified as hs-CRP > 0.5 mg/dl [32]. The high sensitive C-reactive protein was seen as the most sensitive biomarker of the systemic inflammation which strongly associated with MetS than other biomarkers [33,34]. The hs-CRP was then assessed in the current study as the inflammation marker.
Diagnosis of metabolic syndrome
Metabolic syndrome (MetS) was defined by Harmonizing Metabolic Syndrome definition (HMetS) which patients had three or more metabolic abnormalities: elevated waist circumference (WC ≥ 90 cm for men, ≥ 80 cm for women), high serum triglyceride (TG ≥150 mg/dL), low HDL cholesterol (HDL-C <40 mg/dL in men or <50 mg/dL in women), high blood pressure (blood pressure ≥ 130 mmHg systolic or ≥ 85 mmHg diastolic), impaired fasting glucose (elevated fasting plasma glucose, FPG ≥ 100 mg/dL[35], or diagnosed with type 2 diabetes mellitus) [36].
Statistical analysis
The receiver operating characteristic (ROC) curve was used to depict the optimal cut-off value of energy intake for the diagnosis of HMetS. The area under the curve (AUC), and 95% confident interval, sensitivity, and specificity were reported for the overall sample, male, female, aged less than 60 years, 60 years and above, patients with diabetes mellitus (DM), and without DM. The ROC curves were interpreted as the probability that the EI values can correctly discriminate patients with HMetS from those EI values without HMetS, where 0.5 is chance discrimination and 1.0 is perfect discrimination [37].
To determine the optimal cut-off value, two common methods were used, which was the point on the ROC curve closest to (0,1) and the maximum Youden index (J) [38]. The Youden index (J) was calculated as [sensitivity- (1-specificity)], and the point with shortest distance value from the point (0,1) was calculated as [(1—sensitivity)2 + (1—specificity)2] [37,38]. In addition, the positive likelihood ratio (PLR), which summarizes how likely patients with the HMetS were to have a specified value of EI compared with patients without the HMetS. The PLR values were calculated as sensitivity/(1-specificity) [37]. The analyses were performed for the overall sample, and subgroups of male, female, age less than 60 years, 60 years and above, patients with DM, and without DM.
The correlation of energy intake, carbohydrate, protein, and total fat intake with MetS and its components were analyzed by Spearman test. Finally, the logistic regression models were used to examine the association between energy intake and metabolic syndrome in hemodialysis patients, by using newly developed cut-off point and targeted dietary energy intake recommended by NKF-K/DOQI. Since body mass index, hemodialysis vintage, physical activity level, and high sensitive C-reactive protein were reported in number of studies that they associated with metabolic syndrome in hemodialysis patients [33,39–41], which can confound the association between energy intake and MetS. Therefore, these factors will be adjusted in the multivariate analysis.
All statistical analyses were performed with the SPSS for Windows version 20.0 (IBM Corp., New York, USA). The significant level was set at P < 0.05.
Ethical consideration
The study was ethically approved by Taipei Medical University Joint Institutional Review Board (TMU-JIRB No. 201302024), Cathay General Hospital (CGH-OP104001), and Taipei Tzu-Chi Hospital (04-M11-090). The study has been conducted according to the principles expressed in the Declaration of Helsinki. All patients involved in the study have signed the informed consent statement which the subject confidentiality is upheld (S1 File).
Results
Patients’ characteristics
The mean and standard deviation of age was 61.4 ± 11.2 years, 54.3% men, 40.3% overweight and obese, daily dietary energy intake, percentage of carbohydrate, protein, and total fat intake were 28.0 ± 9.4 (kcal/kg), 48.7 ± 9.3, 15.1 ± 3.5, and 35.9 ± 8.6, respectively. The median (IQR) of age among patients less than 60 years old, and 60 years old and above were 53.0 (49.0, 56.0), and 68 (63.0, 74.5), respectively. The prevalence of diagnosed type 2 diabetes mellitus, impaired fasting glucose, elevated waist circumference, high triglyceride, low HDL-Cholesterol, and high blood pressure were 39.5%, 66.3%, 33.7%, 37.2%, 62.2%, and 81.1%, respectively. Among patients, 55.6% were diagnosed with metabolic syndrome (Table 1).
Receiver operating characteristic curve analysis
Results from ROC curve analysis showed that energy intake lower or equal to 26.7 kcal/kg was as a determinant of metabolic syndrome in the overall sample, in male, female, patients aged less than 60 years, and without diabetes. The cut-off point was slightly lower to 26.2 kcal/kg for patients aged 60 years and above, and with diabetes. In the overall sample, results showed 67% sensitivity, 69% specificity, AUC 0.70 (95%CI, 0.63–0.76, P < 0.001), with a positive likelihood ratio of 2.10, highest Youden index of 0.35, and shortest distance to the point (0,1) of 0.21. The final cut-off values selected by Youden index and shortest distance to the point (0,1) were the same (Table 2, Figs 1 and 2).
Abbreviations: DM, diabetes mellitus.
The panel (A) shows results in total sample, (B) in male, (C) in female, (D) in aged < 60 years, (E) in aged 60 years and above, (F) in non-diabetes mellitus, (G) in diabetes mellitus.
The likelihood of HMetS mostly increased with the decreased percentiles of energy intake from 50th to 5th percentiles. The likelihood ratios of HMetS of overall sample, and subgroups were slightly increased from 50th to 20th percentiles, and dramatically increased from 20th to 5th percentiles. The highest likelihood ratios of 8.00, 4.55, 5.09, 2.78, 2.59, 9.26, and 5.44 for total sample, male, female, age less than 60 years, and without diabetes at 5th percentile, age 60 and above at 10th percentile, and with diabetes at 40th percentile, respectively (Fig 3).
Abbreviations: DM, diabetes mellitus.
Association between inadequate energy intake and metabolic syndrome
Results of a spearman correlation analysis show that higher energy intake was significantly associated with lower prevalence of metabolic syndrome and its components (impaired fasting glucose, elevated waist circumference, high triglyceride, low HDL-Cholesterol). Carbohydrate, protein, and total fat intake did not significantly illustrate the association with metabolic syndrome and the metabolic components (Table 3).
The inadequate energy intake was then classified as energy intake lower than the cut-off point of 26.7 kcal/kg for patients aged less than 60 years, and 26.2 kcal/kg for patients aged 60 years and above, named inadequate energy intake for determining the metabolic syndrome (or IEI-M). The prevalence of inadequate energy intake (IEI-M) was 50.6%, and prevalence of IEI defined by National Kidney Foundation Kidney Disease Outcomes Quality Initiative (IEI-K/DOQI) was 71.2% (Table 4).
In the bivariate analysis, IEI was significantly associated with higher prevalence of metabolic syndrome with OR = 4.55, 95% CI, 2.64–7.83, P < 0.001, and OR = 3.75, 95% CI, 2.08–6.76, P < 0.001, for IEI-M, and IEI- K/DOQI, respectively. After controlling for age, gender, body mass index, hemodialysis vintage, physical activity level, and high sensitive C-reactive protein, the association remained significant with OR = 3.24, 95% CI, 1.74–6.05, P < 0.001, and OR = 2.50, 95% CI, 1.28–4.87, P < 0.01, for IEI-M, and IEI- K/DOQI, respectively (Table 4).
Discussion
The results of current study demonstrated the optimal cut-off points of energy intake for determining the MetS were 26.7 kcal/kg/day, and 26.2 kcal/kg/day, which were lower than the K/DOQI recommendation level for energy intake in hemodialysis patients of 35 kcal/kg/day, and 30 kcal/kg/day, for patients aged less than 60 years, and 60 years and above, respectively [20]. The wide distribution range of age between two age groups that could partly explain the wide range of difference between the highest likelihood ratios (2.78 versus 9.26) for age less than 60 years at 5th percentile, and age 60 and above at 10th percentile, respectively. The cut-off values of energy intake among patients without and with diabetes mellitus were 26.7 kcal/kg/day, and 26.2 kcal/kg/day, respectively. The positive likelihood of having MetS among DM patients were extreme high, and cannot be calculated from 5th percentile to 20th percentile of energy intake as the values of “1-specificity” are closed to zero. Among DM patients, the positive likelihood ratio (PLR) was increased from 2.98 at 20th percentile to 5.44 at 40th percentile, and decreased to 2.33 at 50th percentile. In overall, the PLR of having MetS among DM patient was decreased by the increased percentile of energy intake among hemodialysis patients.
To harmonize with K/DOQI guideline for clinical practice, the energy intake can be classified into three levels, as severely inadequate energy intake with EI < 26.7, and < 26.2, moderate inadequate energy intake with 26.7 ≤ EI < 35, and 26.2 ≤ EI < 30, and adequate energy intake with EI ≥ 35, and ≥ 30, for patients aged less than 60 years, and 60 years and above, respectively.
The results demonstrated that energy intake was well established indicator among dietary components which associated with MetS and its components. In addition, the likelihood of the MetS increased with lower percentiles of energy intake in hemodialysis patients. In multivariate regression analysis, the inadequate dietary energy intake related to a higher odd of the MetS, and strongly determined 3.24, and 2.50 folds of harmonized metabolic syndrome (HMetS) via newly developed cut-off points, and those recommended by K/DOQI guideline, respectively. This could be explained that the energy balance can be disrupted in patients with inadequate energy intake, which related to a number of disorders such as risks of cardiovascular diseases, metabolic syndrome [42]. On the other hand, patients who had the adequate consumption of energy-enriched meal while receiving hemodialysis can strongly improve the whole body protein balance and in turn, improve the dialysis outcomes [43].
In addition, the prevalence of inadequate energy intake was high, about two third of HD patients in the current study, which was in the line with previous studies [21,22]. On the other hand, the metabolic syndrome was common in HD patients in present study (55.6% HMetS), which were lower than that in Brazil (74.5%) using diagnostic criteria from Harmonizing Metabolic Syndrome [41], and in the United States (69.3%) using NCEP-ATP III [44]. In HD patients, adequate energy dietary intake was recommended in the K/DOQI guidelines [19,20], to reduce the risk of metabolic syndrome, and improve the hemodialysis outcomes.
The current study presented with a number of limitations. Firstly, dietary intake was subjectively assessed. Fortunately, patients were interviewed for three different days and confirmed by 24-hour recall dietary questionnaire. Secondly, with the cross-sectional nature, the inferences of causal relationship should be cautious, regarding dietary energy intake and the development of metabolic abnormalities and the metabolic syndrome. The study has the strengths including the use of precise and direct measurement of body composition by BIA, and biochemical parameters were examined by standardized laboratory tests. Future studies with different designs were suggested to measure the longitudinal data of energy intake and to investigate the association between dietary intake and metabolic syndrome.
Conclusions
The study demonstrated that the optimal cut-off points of energy intake for determining the MetS among patients aged less than 60 years, or without DM were 26.7 kcal/kg/day, and among patients aged 60 years and above, or with DM were 26.2 kcal/kg/day, respectively. The likelihood of the MetS increased with lower percentiles of energy intake in hemodialysis patients. The inadequate energy intake significantly associated with the higher odd of the MetS. The results indicated that hemodialysis patients with inadequate energy intake should be closely followed up, in order to identify the risks of the metabolic syndrome and have adequate examinations and treatments.
Acknowledgments
The authors express the appreciation to medical staff and patients from Taipei Medical University Hospital, Wan-Fang Hospital, Shuang Ho Hospital, Cathay General Hospital, and Taipei Tzu-Chi Hospital.
References
- 1.
United States Renal Data System. International comparisons. The 2016 Annual Data Report: Epidemiology of kidney disease in the United States: Volume 2 –End-stage Renal Disease (ESRD) in the United States. USRDS Coordinating Center: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2016.
- 2. Lin Y-C, Hsu C-Y, Kao C-C, Chen T-W, Chen H-H, Hsu C-C, et al. Incidence and Prevalence of ESRD in Taiwan Renal Registry Data System (TWRDS): 2005–2012. Acta Nephrologica. 2014;28(2):65–68. http://dx.doi.org/10.6221/AN.2014011
- 3. Gluba A, Mikhailidis DP, Lip GYH, Hannam S, Rysz J, Banach M. Metabolic syndrome and renal disease. Int J Cardiol. 2013;164(2):141–150. pmid:22305775
- 4. Tu S-F, Chou Y-C, Sun C-A, Hsueh S-C, Yang T. The Prevalence of Metabolic Syndrome and Factors Associated with Quality of Dialysis among Hemodialysis Patients in Southern Taiwan. Glob J Health Sci. 2012;4(5):53–62. pmid:22980378
- 5. Vogt BP, Souza PL, Minicucci MF, Martin LC, Barretti P, Caramori JT. Metabolic syndrome criteria as predictors of insulin resistance, inflammation, and mortality in chronic hemodialysis patients. Metab Syndr Relat Disord. 2014;12(8):443–449. pmid:25099153
- 6. Stolic RV, Trajkovic GZ, Peric VM, Stolic DZ, Sovtic SR, Aleksandar JN, et al. Impact of Metabolic Syndrome and Malnutrition on Mortality in Chronic Hemodialysis Patients. J Ren Nutr. 2010;20(1):38–43. pmid:19464925
- 7. Chang Y-M, Shiao C-C, Huang Y-T, Chen IL, Yang C-L, Leu S-C, et al. Impact of metabolic syndrome and its components on heart rate variability during hemodialysis: a cross-sectional study. Cardiovasc Diabetol. 2016;15:16. pmid:26817599
- 8. Nakagawa N, Matsuki M, Yao N, Hirayama T, Ishida H, Kikuchi K, et al. Impact of Metabolic Disturbances and Malnutrition-Inflammation on 6-Year Mortality in Japanese Patients Undergoing Hemodialysis. Ther Apher Dial. 2015;19(1):30–39. pmid:25196142
- 9. Jalalzadeh M, Mousavinasab N, Soloki M, Miri R, Ghadiani MH, Hadizadeh M. Association between metabolic syndrome and coronary heart disease in patients on hemodialysis. Nephrourol Mon. 2015;7(1):e25560. pmid:25738129
- 10. Bonet J, Martinez-Castelao A, Bayés B. Metabolic syndrome in hemodialysis patients as a risk factor for new-onset diabetes mellitus after renal transplant: a prospective observational study. Diabetes Metab Syndr Obes. 2013;6:339–346. pmid:24082792
- 11. Yang S-Y, Chiang C-K, Hsu S-P, Peng Y-S, Pai M-F, Ho T-I, et al. Metabolic Syndrome Predicts Hospitalization in Hemodialysis Patients: A Prospective Asian Cohort Study. Blood Purif. 2007;25(3):252–259. pmid:17429199
- 12. Guarnieri G, Zanetti M, Vinci P, Cattin MR, Pirulli A, Barazzoni R. Metabolic Syndrome and Chronic Kidney Disease. 2010;20(5, Supplement):S19–S23. https://doi.org/10.1053/j.jrn.2010.05.006
- 13. Beto JA, Bansal VK. Medical nutrition therapy in chronic kidney failure: Integrating clinical practice guidelines. J Am Diet Assoc. 2004;104(3):404–409. pmid:14993863
- 14. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial Effects of a Dietary Approaches to Stop Hypertension Eating Plan on Features of the Metabolic Syndrome. Diabetes Care. 2005;28(12):2823–2831. https://doi.org/10.2337/diacare.28.12.2823 pmid:16306540
- 15. Qian F, Korat AA, Malik V, Hu FB. Metabolic Effects of Monounsaturated Fatty Acid–Enriched Diets Compared With Carbohydrate or Polyunsaturated Fatty Acid–Enriched Diets in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care. 2016;39(8):1448–1457. pmid:27457635
- 16. Kent PS, McCarthy MP, Burrowes JD, McCann L, Pavlinac J, Goeddeke-Merickel CM, et al. Academy of Nutrition and Dietetics and National Kidney Foundation: Revised 2014 Standards of Practice and Standards of Professional Performance for Registered Dietitian Nutritionists (Competent, Proficient, and Expert) in Nephrology Nutrition. J Acad Nutr Diet. 2014;114(9):1448–1457.e45. pmid:25169785
- 17. Schoenaker DAJM, Mishra GD, Callaway LK, Soedamah-Muthu SS. The Role of Energy, Nutrients, Foods, and Dietary Patterns in the Development of Gestational Diabetes Mellitus: A Systematic Review of Observational Studies. Diabetes Care. 2015;39(1):16–23. https://doi.org/10.2337/dc15-0540
- 18. Beto JA, Ramirez WE, Bansal VK. Medical Nutrition Therapy in Adults with Chronic Kidney Disease: Integrating Evidence and Consensus into Practice for the Generalist Registered Dietitian Nutritionist. J Acad Nutr Diet. 2014;114(7):1077–1087. pmid:24582998
- 19. Daugirdas JT, Depner TA, Inrig J, Mehrotra R, Rocco MV, Suri RS, et al. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update. Am J Kidney Dis. 2015;66(5):884–930. pmid:26498416
- 20. Kopple JD. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. Am J Kidney Dis. 2001;37(1 Suppl 2):S66–S70. http://dx.doi.org/10.1053/ajkd.2001.20748
- 21. Vaz IMF, Freitas ATVdS, Peixoto MdRG, Ferraz SF, Campos MIVAM. Is energy intake underreported in hemodialysis patients? J Bras Nefrol. 2015;37(3):359–366. pmid:26398646
- 22. Mafra D, Moraes C, Leal VO, Farage NE, Stockler-Pinto MB, Fouque D. Underreporting of Energy Intake in Maintenance Hemodialysis Patients: A Cross-sectional Study. J Ren Nutr. 2012;22(6):578–583. pmid:22227181
- 23. Kopple JD, K/DOQI Workgroup. K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. Am J Kidney Dis. 2000;35(6 Suppl 2):S1–S140. http://dx.doi.org/10.1053/ajkd.2000.6669
- 24. Tzeng MS. From dietary guidelines to daily food guide: the Taiwanese experience. Asia Pac J Clin Nutr. 2008;17 Suppl 1:59–62. http://dx.doi.org/10.6133/apjcn.2008.17.s1.14
- 25.
Ministry of Health and Welfare. Daily Food Guide 2011. Health Promotion Administration: Ministry of Health and Welfare, Taiwan; 2011. Available from: https://health99.hpa.gov.tw/media/public/pdf/21733.pdf.
- 26. Chiu Y-F, Chen Y-C, Wu P-Y, Shih C-K, Chen H-H, Chen H-H, et al. Association Between the Hemodialysis Eating Index and Risk Factors of Cardiovascular Disease in Hemodialysis Patients. J Ren Nutr. 2014;24(3):163–171. pmid:24582758
- 27. Wong T-C, Su H-Y, Chen Y-T, Wu P-Y, Chen H-H, Chen T-H, et al. Ratio of C-Reactive Protein to Albumin Predicts Muscle Mass in Adult Patients Undergoing Hemodialysis. PLoS One. 2016;11(10):e0165403. pmid:27768746
- 28. Wong T-C, Chen Y-T, Wu P-Y, Chen T-W, Chen H-H, Chen T-H, et al. Ratio of Dietary n-6/n-3 Polyunsaturated Fatty Acids Independently Related to Muscle Mass Decline in Hemodialysis Patients. PLoS One. 2015;10(10):e0140402. pmid:26466314
- 29. Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson comorbidity index for use in patients with ESRD. Am J Kidney Dis. 2003;42(1):125–132. http://dx.doi.org/10.1016/S0272-6386(03)00415-3 pmid:12830464
- 30. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–1395. pmid:12900694
- 31. Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the international physical activity questionnaire short form (IPAQ-SF): A systematic review. Int J Behav Nutr Phys Act. 2011;8:115–115. pmid:22018588
- 32. Omae K, Kondo T, Tanabe K. High preoperative C-reactive protein values predict poor survival in patients on chronic hemodialysis undergoing nephrectomy for renal cancer. Urol Oncol. 2015;33(2):67.e9–67.e13. http://doi.org/10.1016/j.urolonc.2014.07.004
- 33. Shahrokh S, Heydarian P, Ahmadi F, Saddadi F, Razeghi E. Association of Inflammatory Biomarkers with Metabolic Syndrome in Hemodialysis Patients. Ren Fail. 2012;34(9):1109–1113. pmid:22889096
- 34. Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, et al. Comparison of serum concentrations of C-reactive protein, TNF-alpha, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance. Diabetes Res Clin Pract. 2004;64(2):99–106. pmid:15063602
- 35. Shaw JE, Zimmet PZ, Alberti KGMM. Point: impaired fasting glucose: The case for the new American Diabetes Association criterion. Diabetes Care. 2006;29(5):1170–1172. pmid:16644659
- 36. Alberti KGMM Eckel RH, Grundy SM Zimmet PZ, Cleeman JI Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645. pmid:19805654
- 37.
Pepe MS. The statistical evaluation of medical tests for classification and prediction. New York, USA: Oxford University Press; 2003.
- 38. Perkins NJ, Schisterman EF. The Inconsistency of “Optimal” Cut-points Using Two ROC Based Criteria. Am J Epidemiol. 2006;163(7):670–675. pmid:16410346
- 39. Alswat KA, Althobaiti A, Alsaadi K, Alkhaldi AS, Alharthi MM, Abuharba WA, et al. Prevalence of Metabolic Syndrome Among the End-Stage Renal Disease Patients on Hemodialysis. 2017;9(8):687–694. https://doi.org/10.14740/jocmr3064w
- 40. Vigan J, Alassani AS, Ahissou MM, Sabi AK, Assogba-Gbindou U, Attolou V, et al. Prevalence of Metabolic Syndrome and Associated Factors among Hemodialysis Patients Monitored at the National Teaching Hospital, Hubert Koutoucou Maga in 2015. Open J Nephrol. 2016;6(4):167–175. http://dx.doi.org/10.4236/ojneph.2016.64022
- 41. Vogt BP, Ponce D, Caramori JCT. Anthropometric Indicators Predict Metabolic Syndrome Diagnosis in Maintenance Hemodialysis Patients. Nutr Clin Pract. 2016;31(3):368–374. pmid:26341917
- 42. Cuppari L, Ikizler TA. Energy Balance in Advanced Chronic Kidney Disease and End-Stage Renal Disease. Semin Dial. 2010;23(4):373–377. pmid:20701716
- 43. Veeneman JM, Kingma HA, Boer TS, Stellaard F, De Jong PE, Reijngoud D-J, et al. Protein intake during hemodialysis maintains a positive whole body protein balance in chronic hemodialysis patients. Am J Physiol Endocrinol Metab. 2003;284(5):E954–E965. pmid:12540372
- 44. Young DO, Lund RJ, Haynatzki G, Dunlay RW. Prevalence of the metabolic syndrome in an incident dialysis population. Hemodial Int. 2007;11(1):86–95. pmid:17257361